Technology Drug Repurposing To Inhibit Nsp15 Endoribonuclease/NendU From SARS-CoV-2 There have been significant research efforts to develop various COVID-19 treatments. Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus i.e. SARS-CoV-2, which has spread rapidly…
Technology Next-gen Immunoregulatory Bioelectronic Patch For Skin Inflammation An electronic system that incorporates living materials as an interfacial layer, specially tailored for managing skin inflammation diseases. The Unmet Need: Chronic skin diseases lack safe, drug-free, continuous monitoring and…
Program Past VCIC Participants 2026 Monarch Fund won the regional Venture Capital Investment Competition. Team members included Angela Huang, Kim Berg, Nick Thomas, Patrick Mispireta, Leah Sidell, and Joe Wang. 2025 First Pick Ventures…
